Minsig Choi
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
- Oncology 18
- Pancreatic and Hepatic Oncology Research 14
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 3
-
- Cancer Genomics and Diagnostics 7
- Co-authors
- Anthony F. Shields (8 shared papers)Lance K. Heilbrun (3 shared papers)Asfar S. Azmi (2 shared papers)Mark M. Zalupski (2 shared papers)Jawana M. Lawhorn‐Crews (1 shared paper)Raghu Venkatramanamoorthy (1 shared paper)Mark D. Kochenderfer (2 shared papers)Alexander I. Spira (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)OncoTargets and Therapy (2 papers)Molecular Case Studies (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Clinical Colorectal Cancer (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Minsig Choi
28 papers receiving 545 citations
Peers
Comparison fields: 5 of 65
- Oncology 329
- Otorhinolaryngology 30
- Cancer Research 80
- Pulmonary and Respiratory Medicine 92
- Hepatology 20
Countries citing papers authored by Minsig Choi
This map shows the geographic impact of Minsig Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minsig Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minsig Choi more than expected).
Fields of papers citing papers by Minsig Choi
This network shows the impact of papers produced by Minsig Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minsig Choi. The network helps show where Minsig Choi may publish in the future.
Co-authors
The 25 scholars most cited alongside Minsig Choi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 82 | |
| 2 | 2010 | 74 | |
| 3 | 2018 | 42 | |
| 4 | 2011 | 39 | |
| 5 | 2016 | 37 | |
| 6 | 2017 | 32 | |
| 7 | 2014 | 31 | |
| 8 | 2011 | 29 | |
| 9 | 2014 | 26 | |
| 10 | 2010 | 23 | |
| 11 | 2019 | 19 | |
| 12 | 2012 | 18 | |
| 13 | 2019 | 18 | |
| 14 | 2015 | 14 | |
| 15 | 2014 | 11 | |
| 16 | 2013 | 11 | |
| 17 | 2013 | 10 | |
| 18 | 2014 | 8 | |
| 19 | 2012 | 6 | |
| 20 | 2012 | 6 |
About Minsig Choi
Minsig Choi is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 28 papers that have together received 553 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Multiple and Secondary Primary Cancers (2 papers), Renal cell carcinoma treatment (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (329 citations), Otorhinolaryngology (30 citations), Cancer Research (80 citations), Pulmonary and Respiratory Medicine (92 citations) and Hepatology (20 citations). Minsig Choi has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Anthony F. Shields, Lance K. Heilbrun, Asfar S. Azmi, Mark M. Zalupski, Jawana M. Lawhorn‐Crews, Raghu Venkatramanamoorthy, Mark D. Kochenderfer, Alexander I. Spira, Stephen A. Geraci and Diana F. Hausman. Their work appears in journals such as Journal of Clinical Oncology, OncoTargets and Therapy, Molecular Case Studies, Critical Reviews in Oncology/Hematology and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.